Sznajder Kristin K, Legro Richard S, Teti Douglas, Mackeen A Dhanya, Mulla Wadia, Simhan Hyagriv, Hwang Wenke
Department of Public Health Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States of America.
Department of Obstetrics and Gynecology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States of America.
PLoS One. 2025 May 15;20(5):e0323891. doi: 10.1371/journal.pone.0323891. eCollection 2025.
Pregnant people are vulnerable to more severe outcomes of COVID-19 compared with their non-pregnant counterparts. Research is needed to systematically test the degree to which COVID-19 during pregnancy increases the risk for adverse maternal, perinatal, and infant health and development outcomes and whether social determinants of health or psychological/psychosocial health outcomes confound or intensify the risk. This protocol paper describes a prospective cohort study using electronic health record (EHR) and patient-reported data from four large health systems in Pennsylvania to examine neighborhood, social, and health factors predicting COVID-19 and its severity, birth weight, gestational age, and vaccination among pregnant people to 12 months postpartum.
Our study will be conducted with two aims. Aim 1 will combine maternal and infant clinical data and neighborhood data from four health systems in Pennsylvania participating in a PCORI-supported clinical research network. The cohort will include all people who were pregnant between June 2019 and May 2025, along with linkage to their newborn delivery records. In Aim 2, a subset of pregnant people from the Aim 1 cohort will be recruited to participate in a series of surveys from pregnancy to one year postpartum. Survey instruments will be developed to collect patient-reported health and social information as well as patient-centered outcomes depicting whether and how the COVID-19 pandemic is impacting pregnant people and their newborns. Survey data will be collected during pregnancy and at one, six, and 12 months postpartum. Survey data will be linked with data from Aim 1 for analysis.
Ethical approval has been obtained at all sites. Subcontracts and data use agreements have been established. EHR data across health systems are being collected and curated. Surveys have been developed and recruitment and retention procedures implemented. Recruitment for the survey aim of the study began in July 2023 and is ongoing.
This study will advance multi-site research involving pregnant people across diverse communities in a time of public health crisis. Data from this study will provide additional evidence of the impact of the COVID-19 pandemic on pregnant people and their infants. Findings will help guide future clinical and public health practices in pandemics for pregnant people.
与未怀孕的人相比,孕妇更容易出现新冠病毒疾病(COVID-19)的更严重后果。需要开展研究,以系统地测试孕期感染COVID-19会在多大程度上增加孕产妇、围产期及婴儿不良健康和发育结局的风险,以及健康的社会决定因素或心理/社会心理健康结局是否会混淆或加剧这种风险。本方案文件描述了一项前瞻性队列研究,该研究使用宾夕法尼亚州四个大型医疗系统的电子健康记录(EHR)和患者报告数据,以检查预测孕妇感染COVID-19及其严重程度、出生体重、孕周和产后12个月内疫苗接种情况的邻里、社会和健康因素。
我们的研究将有两个目标。目标1将结合宾夕法尼亚州四个参与由患者为中心的结果研究所(PCORI)支持的临床研究网络的医疗系统的孕产妇和婴儿临床数据以及邻里数据。该队列将包括2019年6月至2025年5月期间所有怀孕的人,并与他们的新生儿分娩记录建立关联。在目标2中,将从目标1队列中招募一部分孕妇,参与从孕期到产后一年的一系列调查。将开发调查工具,以收集患者报告的健康和社会信息以及以患者为中心的结局,描述COVID-19大流行是否以及如何影响孕妇及其新生儿。调查数据将在孕期以及产后1个月、6个月和12个月收集。调查数据将与目标1的数据进行关联分析。
所有研究地点均已获得伦理批准。已签订分包合同并建立数据使用协议。正在收集和整理各医疗系统的EHR数据。已开发调查工具,并实施了招募和保留程序。该研究调查目标的招募工作于2023年7月开始,目前仍在进行。
本研究将推动在公共卫生危机时期涉及不同社区孕妇的多地点研究。本研究的数据将为COVID-19大流行对孕妇及其婴儿的影响提供更多证据。研究结果将有助于指导未来针对孕妇的大流行期间临床和公共卫生实践。